• At CPT we are committed to ensuring the best possible experience for all artists, audience members and other visitors to our space. We welcome customers and artists with disabilities and are pleased to assist you in your visit. 

    If you have any questions or enquiries, please do get in touch by phone at 020 7419 4841 or email at foh@cptheatre.co.uk.

  • About CPT

    Image: Angela Christofilou

    CPT brings together artists and everyone else to connect, imagine, be heard and be entertained. It makes space for the theatre – and the theatre-makers – of tomorrow, it celebrates community and it strives to create a more equitable and caring world through extraordinary performance made by and for a wide range of people.

    Over 30 years, CPT has fulfilled a national leadership role in the field of innovative contemporary performance. We deliver a wide-ranging programme that champions the next generation of theatre-makers, working with and launching the careers of ground-breaking artists including: Fevered Sleep, Chris Thorpe, Emily Lim (who now runs the National Theatre’s Public Acts programme), Scottee, Common Wealth and Nouveau Riche (Queens of Sheba; Typical) – among many, many others. We have an excellent reputation for supporting early-career artists in this field, and for attracting a consistently young and diverse audience.

    Our programming is centred around themed festivals that tackle socio-political issues affecting our wider community. E.g. Common People, exploring working-class identity and experience (2018) and Come As You Are, celebrating trans and gender-queer work (2017). Since 1997, CPT has programmed the annual Sprint festival, London’s best-established festival of new and unusual theatre, and since 2013 Calm Down, Dear, the UK’s first and only festival of innovative feminist theatre. For the last decade, we have also run the unique artist support/peer network programme Starting Blocks. To find out more about how we support artists, click here.

    CPT is also a proud member of its Camden community. Since 2016, it has co-run Camden Youth Theatre in collaboration with New Diorama Theatre.  A major building upgrade in 2021 allowed us to significantly increase our local community offer: we now work year-round with Camden residents on a tailored programme of arts and cultural projects and activities.

    A Starting Blocks performer in the CPT basement space with a microphone watched by a group of people standing

    Programming

    We support emerging artists to make inventive theatre - particularly about issues that matter to people right now. 

    A photo of the CPT board outside the theatre

    Support Us

    Support our artists, community and young people to make inventive new theatre

    Our Mission Statement

    Our mission is to support young and early-career artists making inventive new theatre – particularly about issues that matter to people right now. By doing so, we will champion different ways of thinking about and living in the world. Our work is rooted in the communities of Camden and London more widely, and through it, we celebrate the bold, the spirited and the unconventional. By presenting a diverse range of voices and perspectives on our stage, our work speaks to an audience reflective of the makeup of the UK.

    The Team

    Meet the lovely faces behind CPT!

    A newspaper clipping of the opening of CPT, four founders look towards the camera

    The Story So Far...

    A brief account of some highlights in CPT’s history since it was established in 1994.

    Teenagers wearing headphones and singing into mic's, under a red light

    Camden Youth Theatre

    Camden Youth Theatre is free to attend and introduces young people who live or go to school in Camden, to the skills they need to make their own inventive new theatre.

    Photo of theatre building from across the street

    Capital Development

    Our building got a makeover!

    "It is precisely these types of projects, involving these types of people, in these types of theatres that make London what it is."

    The Lancet